[EN] TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE AND/OR EPX<br/>[FR] INHIBITEURS DE LA MYÉLOPEROXYDASE ET/OU DE L'EPX À BASE DE TRIAZOLOPYRIDINES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2017161145A1
公开(公告)日:2017-09-21
The present invention provides compounds of Formula (I); wherein the substituents are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
本发明提供了式(I)的化合物;其中取代基各自如说明书中所定义,以及包含任一此类新颖化合物的组合物。这些化合物是髓过氧化物酶(MPO)抑制剂和/或嗜酸性粒细胞过氧化物酶(EPX)抑制剂,并且可用于治疗和/或预防动脉粥样硬化、心力衰竭、慢性阻塞性肺病(COPD)及相关疾病。